Liraglutide increases the catabolism of apolipoprotein B100-containing lipoproteins in patients with type 2 diabetes and reduces proprotein convertase subtilisin/kexin type 9 expression
August 7 Product: Amneals Crexont Indication: Parkinsons disease Second time was the charm for Amneal Pharmaceuticals, which won approval Wednesday for Crexont, its novel oral formulation of carbidopa/levodopa (CD/LD), for Parkinsons disease
What the Latest Clinical Trial Data Shows The TRIUMPH-4 trial, whose results Eli Lilly announced in December 2025, is the first completed Phase 3 study for retatrutide
In the United States, Wegovy is available for adolescents aged 12 and older who meet specific criteria
ST activates guanylate cyclase, resulting in elevated intracellular cGMP levels, whereas LT activates adenylyl cyclase, leading to increased cAMP levels 123
The digestive system is highly sensitive to stress hormones, which can alter motility patterns and increase visceral sensitivity